Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2025 Earnings Call Transcript February 26, 2026
Akebia Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.04614 EPS, expectations were $-0.03.
Operator: Thank you for standing by. Welcome to Akebia Therapeutics, Inc.’s Fourth Quarter 2025 Financial Results Conference Call. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. To ask a question...
